Tcw Group Inc Relay Therapeutics, Inc. Transaction History

Tcw Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$29.75 - $37.99 $2.41 Million - $3.08 Million	-80,943 Closed	0 $0
Q2 2021 Jul 23, 2021	SELL	$27.5 - $38.19 $197,587 - $274,395	-7,185 Reduced 8.15%	80,943 $2.96 Million
Q1 2021 May 05, 2021	SELL	$32.52 - $61.53 $650,855 - $1.23 Million	-20,014 Reduced 18.51%	88,128 $3.05 Million
Q4 2020 Feb 02, 2021	SELL	$35.51 - $54.03 $1.2 Million - $1.83 Million	-33,793 Reduced 23.81%	108,142 $4.49 Million
Q3 2020 Oct 30, 2020	BUY	$32.81 - $45.1 $4.66 Million - $6.4 Million	141,935 New	141,935 $6.05 Million

186

133M

16.7K

18K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $698M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

Stay updated on Tcw Group Inc with notifications on news.